Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study.
about
Erythropoietin: powerful protection of ischemic and post-ischemic brainClinical implications of cardiac hyperpolarized magnetic resonance imagingPyruvate: metabolic protector of cardiac performance.Competition of pyruvate with physiological substrates for oxidation by the heart: implications for studies with hyperpolarized [1-13C]pyruvate.The positive inotropic effect of pyruvate involves an increase in myofilament calcium sensitivity.Cardiac anaplerosis in health and disease: food for thought.Intracoronary pyruvate in cardiogenic shock as an adjunctive therapy to catecholamines and intra-aortic balloon pump shows beneficial effects on hemodynamics.Triiodothyronine increases myocardial function and pyruvate entry into the citric acid cycle after reperfusion in a model of infant cardiopulmonary bypass.Pyruvate in the correction of intracellular acidosis: a metabolic basis as a novel superior buffer.Metabolic cardioprotection by pyruvate: recent progress.Pyruvate restores β-adrenergic sensitivity of L-type Ca(2+) channels in failing rat heart: role of protein phosphataseExcitation-contraction coupling and mitochondrial energetics.Superior cardiac function via anaplerotic pyruvate in the immature swine heart after cardiopulmonary bypass and reperfusionRyanodine receptor-mediated arrhythmias and sudden cardiac death.Human Hepatocellular Carcinoma Metabolism: Imaging by Hyperpolarized (13)C Magnetic Resonance Spectroscopy.Potential of metabolic agents as adjunct therapies in heart failure.Cardiovascular applications of hyperpolarized contrast media and metabolic tracers.Metabolic fingerprint of ischaemic cardioprotection: importance of the malate-aspartate shuttle.Cardiac inotropes: current agents and future directions.Myocardial energetics in heart failure.Using [1-(13) C]lactic acid for hyperpolarized (13) C MR cardiac studies.Hyperpolarized [(13)C]ketobutyrate, a molecular analog of pyruvate with modified specificity for LDH isoforms.Simultaneous investigation of cardiac pyruvate dehydrogenase flux, Krebs cycle metabolism and pH, using hyperpolarized [1,2-(13)C2]pyruvate in vivoAntioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state.Myocardial O2 consumption in porcine left ventricle is heterogeneously distributed in parallel to heterogeneous O2 delivery.Pyruvate modulates cardiac sarcoplasmic reticulum Ca2+ release in rats via mitochondria-dependent and -independent mechanisms.The intermediary metabolite pyruvate attenuates stunning and reduces infarct size in in vivo porcine myocardium.Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure.Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation.Pyruvate enhancement of cardiac performance: Cellular mechanisms and clinical application.New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data.Pyruvate potentiates inotropic effects of isoproterenol and Ca(2+) in rabbit cardiac muscle preparations.A metabolomics study of Qiliqiangxin in a rat model of heart failure: a reverse pharmacology approach.Influence of pyruvate on economy of contraction in isolated rabbit myocardium.Efficacy of exogenous pyruvate in Trembler mouse model of Charcot-Marie-Tooth neuropathy
P2860
Q26999392-ACE672AB-DF9E-4515-8A81-974D7C264D63Q27025172-4DBC036E-3E40-4AC3-A80A-49B33BC20816Q33827938-D413C077-6724-4146-AB9B-A70F63721945Q33840708-C1DAFAB2-DE20-43D6-A1F0-D3662947B38CQ34730765-C3928F7A-2CF5-4B8C-B515-05DCB054EA25Q34808534-0DF878F2-6373-48C4-BDAA-39CB08B8A98BQ34820186-F37DE897-888C-4EBF-BD5A-A2A79BAE6410Q35850056-D4C91A7A-CB60-4566-9B89-065D518273A5Q36054465-9AD34E1E-39B2-4FFA-8D4F-7B0978D8BA0EQ36177933-067EA604-06B4-4550-87D8-B63E0FCFA937Q36837883-3AE810EE-2752-48CF-8CAD-E8426F404B83Q36893596-2FD4CD4C-34EC-46EB-863F-068E3ACFBF42Q37038787-C3D7BAB0-855E-46E6-B551-FC82A17A84DFQ37248371-EED45733-DA01-4569-85D7-D4A4508E6970Q37287105-AC600B26-02CB-4675-9FD9-A67E188A32FBQ37608595-B535CF97-C472-4F81-914E-062C7C163F29Q37637734-437541D8-34F4-4BC2-9A8F-D78A10C2A77EQ37846991-3E5B6848-44B3-4E89-A5A2-B2B173E62834Q37851240-1DF0C6DC-37A0-4E90-B46C-EF48D69160A9Q38112349-7D1A76AA-AC8A-405E-8743-E649925E847CQ39156315-9E32383D-90F8-4A4A-8A12-35B2C08E96CCQ41837726-AD8342EF-61D6-4C96-920F-13D0E1E0CFC8Q42067957-FF2B6763-C628-441A-8F0F-6AE2A521AF98Q42495011-EACABA7D-EAAB-4EA1-B5CE-9B1472EE9ACCQ42627158-D5106324-870E-4EC0-8621-55C5263126ACQ44489966-D7E8303B-89E2-43FA-A830-369042720E68Q44612927-E110D19A-5214-4E3A-A32A-1055574F4A8DQ44776913-4300C1DE-C55D-463D-8DFF-10E0A2EEDD12Q44932395-604D4B48-AFDD-45DA-B1F9-CC95A04D56B2Q46258459-793A1FD8-1242-4F91-90B3-3475225BAD8AQ47113843-3B34F241-F2A4-4FB0-BA5C-41C030DBAC67Q48748035-A949C36D-2FE3-4CF7-BE17-CA69D7C09BD5Q50351086-35DA83DA-7FD1-47A7-8765-022A27AB5F18Q52925848-756092C4-157E-4DD0-8539-041AEF90ED52Q58702974-21557E84-DCDE-4B78-ACD7-A0E89BF2A468
P2860
Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Haemodynamic effects of intrac ...... heart failure: an open study.
@ast
Haemodynamic effects of intrac ...... heart failure: an open study.
@en
type
label
Haemodynamic effects of intrac ...... heart failure: an open study.
@ast
Haemodynamic effects of intrac ...... heart failure: an open study.
@en
prefLabel
Haemodynamic effects of intrac ...... heart failure: an open study.
@ast
Haemodynamic effects of intrac ...... heart failure: an open study.
@en
P2093
P1433
P1476
Haemodynamic effects of intrac ...... heart failure: an open study.
@en
P2093
P304
P356
10.1016/S0140-6736(98)06423-X
P407
P577
1999-04-01T00:00:00Z